Brandes Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cemex
CX
|
+$34.2M |
| 2 |
Halliburton
HAL
|
+$24.6M |
| 3 |
Takeda Pharmaceutical
TAK
|
+$8.64M |
| 4 |
United Therapeutics
UTHR
|
+$6.04M |
| 5 |
NETGEAR
NTGR
|
+$5.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$190M |
| 2 |
Copa Holdings
CPA
|
+$43.7M |
| 3 |
SWIR
Sierra Wireless
SWIR
|
+$40.2M |
| 4 |
APA Corp
APA
|
+$23.2M |
| 5 |
NXP Semiconductors
NXPI
|
+$18.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.02% |
| 2 | Financials | 21.69% |
| 3 | Industrials | 12.8% |
| 4 | Technology | 9.92% |
| 5 | Materials | 8.57% |
Similar funds
Brandes Investment Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Brandes Investment Partners held 154 positions worth $3.87B, down 14% from $4.49B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Brandes Investment Partners withdrew a net $443M in Q3 2019, closing 16 positions and reducing 107 holdings. Its most notable exit was APA Corp, an estimated $23.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
Against the trend, Brandes Investment Partners opened a new position in iShares MSCI ACWI ex US ETF worth $3.42M.
- Brandes Investment Partners's largest Q3 2019 buy was iShares MSCI ACWI ex US ETF: 74,193 shares worth $3.42M.
- Brandes Investment Partners added most to Cemex in Q3 2019, an estimated $34.2M increase.
- Brandes Investment Partners's biggest Q3 2019 reduction was UBS Group, cutting an estimated $190M.
- Brandes Investment Partners fully exited APA Corp in Q3 2019, selling an estimated $23.2M.
- Brandes Investment Partners's ten largest holdings make up 37% of its $3.87B portfolio in Q3 2019.
- Brandes Investment Partners opened 11 new positions and closed 16 in Q3 2019.
- Brandes Investment Partners's portfolio value fell 14% quarter-over-quarter to $3.87B.
Based on Brandes Investment Partners's 13F filing for Q3 2019, filed 13 Nov 2019.